Skip to main content
Top
Published in: BMC Geriatrics 1/2022

Open Access 01-12-2022 | Antidepressant Drugs | Research

The association of change in peak oxygen uptake with use of psychotropics in community-dwelling older adults - The Generation 100 study

Authors: Trude Carlsen, Dorthe Stensvold, Ulrik Wisløff, Linda Ernstsen, Thomas Halvorsen

Published in: BMC Geriatrics | Issue 1/2022

Login to get access

Abstract

Background

The use of psychotropics is high among the older population and may have detrimental effects on their physical and mental health. Cardiorespiratory fitness (CRF) is a strong and modifiable measure of health and declines with age. We aimed to study the association of change in CRF with use of psychotropics in community-dwelling older adults.

Methods

We analyzed longitudinal data from 1531 older adults from the Generation 100 study, aged 70–77 years at inclusion, and with a permanent address in Trondheim, Norway. Data on objectively measured peak oxygen uptake (VO2peak) were linked with register data from the Norwegian Prescription Database on prescribed psychotropics. The included psychotropics were antidepressants (N06A), antipsychotics (N05A), anxiolytics (N05B), hypnotics and sedatives (N05C), and N03AE (benzodiazepine derivatives). Analyses were done on any psychotropics as one group, and on the following separate groups: antidepressants (N06A), benzodiazepines (N05BA, N05CD, and N03AE), and z-hypnotics (N05CF). Peak oxygen uptake was measured four times over a five-year period and corresponding medication use was measured as defined daily doses (DDD). A random effects estimator was applied to investigate the association of change in VO2peak with the use of psychotropics.

Results

We found a statistically significant curvilinear association of change in VO2peak with use of any psychotropics and antidepressants. For VO2peak up to ~ 40 ml/kg/min, each 1 ml/kg/min increase was associated by a 3.3 DDD and 2.5 DDD decrease in use of any psychotropics and antidepressants, respectively. A bottoming-out effect was found and increases in VO2peak above ~ 40 ml/kg/min showed increased use of any psychotropics and antidepressants. However, the association of change in VO2peak with use was stronger for changes in the lower continuum of VO2peak levels and decreased with increasing VO2peak. No statistically significant association of change in VO2peak with use of benzodiazepines and z-hypnotics were found. However, because of a non-randomized design, we cannot rule out the possibility of confounding by indication.

Conclusions

The results of this study show a curvilinear association of change in VO2peak with use of any psychotropics and antidepressants in older adults. This relationship adds a new viewpoint on the adverse effects of psychotropic use and should be considered in interventions and policies aimed at reducing psychotropic medication use among the older population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Qato DM, et al. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176(4):473–82.CrossRef Qato DM, et al. Changes in prescription and over-the-counter medication and dietary supplement use among older adults in the United States, 2005 vs 2011. JAMA Intern Med. 2016;176(4):473–82.CrossRef
2.
go back to reference Stephenson CP, Karanges E, McGregor IS. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust N Z J Psychiatry. 2013;47(1):74–87.CrossRef Stephenson CP, Karanges E, McGregor IS. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust N Z J Psychiatry. 2013;47(1):74–87.CrossRef
3.
go back to reference Ilyas S, Moncrieff J. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. Br J Psychiatry. 2012;200(5):393–8.CrossRef Ilyas S, Moncrieff J. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. Br J Psychiatry. 2012;200(5):393–8.CrossRef
4.
go back to reference Carrasco-Garrido P, et al. National trends (2003-2009) and factors related to psychotropic medication use in community-dwelling elderly population. Int Psychogeriatr. 2013;25(2):328–38.CrossRef Carrasco-Garrido P, et al. National trends (2003-2009) and factors related to psychotropic medication use in community-dwelling elderly population. Int Psychogeriatr. 2013;25(2):328–38.CrossRef
5.
go back to reference Sommerschild H. Drug consumption in Norway 2016–2020 - data from Norwegian drug wholesales statistics and the Norwegian prescription database. Oslo: Norwegian Institute of Public Health; 2021. Sommerschild H. Drug consumption in Norway 2016–2020 - data from Norwegian drug wholesales statistics and the Norwegian prescription database. Oslo: Norwegian Institute of Public Health; 2021.
6.
go back to reference Gutsmiedl K, et al. How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysis. BMC Psychiatry. 2020;20(1):102.CrossRef Gutsmiedl K, et al. How well do elderly patients with major depressive disorder respond to antidepressants: a systematic review and single-group meta-analysis. BMC Psychiatry. 2020;20(1):102.CrossRef
7.
go back to reference Bakken MS, et al. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian prescription database and the Norwegian hip fracture registry. Age Ageing. 2013;42(4):514–20.CrossRef Bakken MS, et al. Increased risk of hip fracture among older people using antidepressant drugs: data from the Norwegian prescription database and the Norwegian hip fracture registry. Age Ageing. 2013;42(4):514–20.CrossRef
8.
go back to reference Bakken MS, et al. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. Eur J Clin Pharmacol. 2014;70(7):873–80.CrossRef Bakken MS, et al. Risk of hip fracture among older people using anxiolytic and hypnotic drugs: a nationwide prospective cohort study. Eur J Clin Pharmacol. 2014;70(7):873–80.CrossRef
9.
go back to reference Park H, et al. Medications associated with falls in older people: systematic review of publications from a recent 5-year period. Eur J Clin Pharmacol. 2015;71(12):1429–40.CrossRef Park H, et al. Medications associated with falls in older people: systematic review of publications from a recent 5-year period. Eur J Clin Pharmacol. 2015;71(12):1429–40.CrossRef
11.
go back to reference Jennum P, et al. Increased all-cause mortality with use of psychotropic medication in dementia patients and controls: a population-based register study. Eur Neuropsychopharmacol. 2015;25(11):1906–13.CrossRef Jennum P, et al. Increased all-cause mortality with use of psychotropic medication in dementia patients and controls: a population-based register study. Eur Neuropsychopharmacol. 2015;25(11):1906–13.CrossRef
12.
go back to reference Weich S, et al. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. Bmj. 2014;348:g1996.CrossRef Weich S, et al. Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. Bmj. 2014;348:g1996.CrossRef
14.
15.
go back to reference Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.CrossRef Mangoni AA, Jackson SH. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. 2004;57(1):6–14.CrossRef
16.
go back to reference Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (part II). Clin Pharmacokinet. 1991;21(4):262–73.CrossRef Greenblatt DJ, Harmatz JS, Shader RI. Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (part II). Clin Pharmacokinet. 1991;21(4):262–73.CrossRef
18.
go back to reference Becofsky KM, et al. A prospective study of fitness, fatness, and depressive symptoms. Am J Epidemiol. 2015;181(5):311–20.CrossRef Becofsky KM, et al. A prospective study of fitness, fatness, and depressive symptoms. Am J Epidemiol. 2015;181(5):311–20.CrossRef
19.
go back to reference Sui X, et al. Prospective study of cardiorespiratory fitness and depressive symptoms in women and men. J Psychiatr Res. 2009;43(5):546–52.CrossRef Sui X, et al. Prospective study of cardiorespiratory fitness and depressive symptoms in women and men. J Psychiatr Res. 2009;43(5):546–52.CrossRef
20.
go back to reference Zou D, et al. Insomnia and cardiorespiratory fitness in a middle-aged population: the SCAPIS pilot study. Sleep Breath. 2019;23(1):319–26.CrossRef Zou D, et al. Insomnia and cardiorespiratory fitness in a middle-aged population: the SCAPIS pilot study. Sleep Breath. 2019;23(1):319–26.CrossRef
21.
go back to reference Strand LB, et al. Insomnia symptoms and cardiorespiratory fitness in healthy individuals: the Nord-Trøndelag health study (HUNT). Sleep. 2013;36(1):99–108.CrossRef Strand LB, et al. Insomnia symptoms and cardiorespiratory fitness in healthy individuals: the Nord-Trøndelag health study (HUNT). Sleep. 2013;36(1):99–108.CrossRef
22.
go back to reference Kandola AA, et al. The association between cardiorespiratory fitness and the incidence of common mental health disorders: a systematic review and meta-analysis. J Affect Disord. 2019;257:748–57.CrossRef Kandola AA, et al. The association between cardiorespiratory fitness and the incidence of common mental health disorders: a systematic review and meta-analysis. J Affect Disord. 2019;257:748–57.CrossRef
23.
go back to reference Lahti J, et al. Leisure-time physical activity and psychotropic medication: a prospective cohort study. Prev Med. 2013;57(3):173–7.CrossRef Lahti J, et al. Leisure-time physical activity and psychotropic medication: a prospective cohort study. Prev Med. 2013;57(3):173–7.CrossRef
24.
go back to reference Stubbs B, et al. Bidirectional longitudinal relationship between leisure-time physical activity and psychotropic medication usage: a register linked follow-up study. Psychiatry Res. 2017;247:208–13.CrossRef Stubbs B, et al. Bidirectional longitudinal relationship between leisure-time physical activity and psychotropic medication usage: a register linked follow-up study. Psychiatry Res. 2017;247:208–13.CrossRef
25.
go back to reference Stensvold D, et al. A randomised controlled study of the long-term effects of exercise training on mortality in elderly people: study protocol for the generation 100 study. BMJ Open. 2015;5(2):e007519.CrossRef Stensvold D, et al. A randomised controlled study of the long-term effects of exercise training on mortality in elderly people: study protocol for the generation 100 study. BMJ Open. 2015;5(2):e007519.CrossRef
26.
go back to reference Stensvold D, et al. Effect of exercise training for five years on all cause mortality in older adults-the generation 100 study: randomised controlled trial. Bmj. 2020;371:m3485.CrossRef Stensvold D, et al. Effect of exercise training for five years on all cause mortality in older adults-the generation 100 study: randomised controlled trial. Bmj. 2020;371:m3485.CrossRef
31.
go back to reference Dieleman JL, Templin T. Random-effects, fixed-effects and the within-between specification for clustered data in observational health studies: a simulation study. PLoS One. 2014;9(10):e110257.CrossRef Dieleman JL, Templin T. Random-effects, fixed-effects and the within-between specification for clustered data in observational health studies: a simulation study. PLoS One. 2014;9(10):e110257.CrossRef
32.
go back to reference Baumeister SE, et al. Associations of leisure-time and occupational physical activity and cardiorespiratory fitness with incident and recurrent major depressive disorder, depressive symptoms, and incident anxiety in a general population. J Clin Psychiatry. 2017;78(1):e41–7.CrossRef Baumeister SE, et al. Associations of leisure-time and occupational physical activity and cardiorespiratory fitness with incident and recurrent major depressive disorder, depressive symptoms, and incident anxiety in a general population. J Clin Psychiatry. 2017;78(1):e41–7.CrossRef
33.
go back to reference Gianfredi V, et al. The association between cardio-respiratory fitness and incident depression: the Maastricht study. J Affect Disord. 2021;279:484–90.CrossRef Gianfredi V, et al. The association between cardio-respiratory fitness and incident depression: the Maastricht study. J Affect Disord. 2021;279:484–90.CrossRef
34.
go back to reference Helgerud J, et al. Aerobic high-intensity intervals improve VO2max more than moderate training. Med Sci Sports Exerc. 2007;39(4):665–71.CrossRef Helgerud J, et al. Aerobic high-intensity intervals improve VO2max more than moderate training. Med Sci Sports Exerc. 2007;39(4):665–71.CrossRef
35.
go back to reference Støren Ø, et al. The effect of age on the V˙O2max response to high-intensity interval training. Med Sci Sports Exerc. 2017;49(1):78–85.CrossRef Støren Ø, et al. The effect of age on the V˙O2max response to high-intensity interval training. Med Sci Sports Exerc. 2017;49(1):78–85.CrossRef
36.
go back to reference Papasavvas T, et al. Depression symptom severity and cardiorespiratory fitness in healthy and depressed adults: a systematic review and Meta-analysis. Sports Med. 2016;46(2):219–30.CrossRef Papasavvas T, et al. Depression symptom severity and cardiorespiratory fitness in healthy and depressed adults: a systematic review and Meta-analysis. Sports Med. 2016;46(2):219–30.CrossRef
37.
go back to reference Kandola AA, et al. Individual and combined associations between cardiorespiratory fitness and grip strength with common mental disorders: a prospective cohort study in the UK biobank. BMC Med. 2020;18(1):303.CrossRef Kandola AA, et al. Individual and combined associations between cardiorespiratory fitness and grip strength with common mental disorders: a prospective cohort study in the UK biobank. BMC Med. 2020;18(1):303.CrossRef
39.
go back to reference Sui X, et al. Cardiorespiratory fitness and all-cause mortality in men with emotional distress. Mayo Clin Proc. 2017;92(6):918–24.CrossRef Sui X, et al. Cardiorespiratory fitness and all-cause mortality in men with emotional distress. Mayo Clin Proc. 2017;92(6):918–24.CrossRef
40.
go back to reference Firth J, et al. The lancet psychiatry commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry. 2019;6(8):675–712.CrossRef Firth J, et al. The lancet psychiatry commission: a blueprint for protecting physical health in people with mental illness. Lancet Psychiatry. 2019;6(8):675–712.CrossRef
Metadata
Title
The association of change in peak oxygen uptake with use of psychotropics in community-dwelling older adults - The Generation 100 study
Authors
Trude Carlsen
Dorthe Stensvold
Ulrik Wisløff
Linda Ernstsen
Thomas Halvorsen
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-022-03262-6

Other articles of this Issue 1/2022

BMC Geriatrics 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine